Though JMJD6 has been identified as an independent marker for poor prognosis in various cancers—such as lung adenocarcinoma, breast cancer, and colon cancer—its role in relation to OSCC is not absolutely clear. This evidence concerns the gene JMJD6 and colonic neoplasm.